Company: NDRA
Filing Date: 2025-11-28
Form Type: 8-K
Source: 0001213900-25-116103
Chunk: 0

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-28
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                             
         10.1      Consulting Agreement, dated as of November 28, 2025 by and between ENDRA Life Sciences Inc. and Michael Thornton        
         10.2      Advisory Services Agreement, dated as of November 28, 2025 by and between ENDRA Life Sciences Inc. and Richard Jacroux  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                             

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ENDRA Life Sciences Inc.                                            
  November 28, 2025                                                   
  By:                           /s/ Alexander Tokman                  
  Name:                         Alexander Tokman                      
  Title:                        Chief Executive Officer and Chairman